SCHEMBL7026526

SCHEMBL7026526

CN1CCN(c2cccc3c2CC(NC(=O)c2ccc(CN4CCOCC4)cc2)CC3)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.57
▸ RAB9A P51151 3/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ NPC1 O15118 2/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ HRH3 Q9Y5N1 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ KCNH2 Q12809 2/20 0.47
▸ SCN9A Q15858 2/20 0.47
▸ SCN5A Q14524 1/20 0.46
▸ MTNR1A P48039 1/20 0.46
▸ MTNR1B P49286 1/20 0.46
▸ HIF1A Q16665 2/20 0.45
▸ EPAS1 Q99814 2/20 0.45
▸ HDAC6 Q9UBN7 2/20 0.44
▸ HDAC1 Q13547 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ MAPK14 Q16539 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7024382 0.89 LMNA (0.51) KMT2ASMN1; SMN2KCNH2MTNR1AMTNR1B
SCHEMBL7024053 0.88 DRD2 (0.50) KCNH2SCN9ASCN5AMTNR1AMTNR1B
SCHEMBL6820453 0.88 DRD2 (0.50) KCNH2SCN9ASCN5AMTNR1AMTNR1B
SCHEMBL3830330 0.88 DRD2 (0.50) KCNH2SCN9ASCN5AMTNR1AMTNR1B
SCHEMBL7023935 0.86 KCNH2 (0.48) KMT2AHRH3KCNH2SCN9ASCN5A
SCHEMBL7024691 0.86 KCNH2 (0.48) KMT2AHRH3KCNH2SCN9ASCN5A
SCHEMBL7029157 0.86 KCNH2 (0.52) KMT2AKCNH2SCN9ASCN5AMTNR1A
SCHEMBL7030362 0.86 KCNH2 (0.52) KMT2AKCNH2SCN9ASCN5AMTNR1A
SCHEMBL7032007 0.84 MTNR1A (0.54) KMT2AKCNH2SCN9ASCN5AMTNR1A
SCHEMBL7032003 0.84 MTNR1A (0.54) KMT2AKCNH2SCN9ASCN5AMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888319-B1 SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES ASTRAZENECA AB (SE) 2003-01-29 — — EP claimed
US-6124283-A Substituted 1,2,3,4-tetrahydronaphthalene derivatives ASTRA AKTIEBOLAG (SE) 2000-09-26 — — US claimed
EP-0888319-A1 SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES Astra Aktiebolag (SE) 1999-01-07 — — EP claimed
WO-1997034883-A1 SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES ASTRA AKTIEBOLAG (SE) 1997-09-25 — — WO claimed
EP-0888319-B1 SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES ASTRAZENECA AB (SE) 2003-01-29 — — EP disclosed
US-6410530-B1 CENTRAL NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ASTRAZENECA AB (SE) 2002-06-25 — — US disclosed
US-6124283-A Substituted 1,2,3,4-tetrahydronaphthalene derivatives ASTRA AKTIEBOLAG (SE) 2000-09-26 — — US disclosed
EP-0888319-A1 SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES Astra Aktiebolag (SE) 1999-01-07 — — EP disclosed
WO-1997034883-A1 SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES ASTRA AKTIEBOLAG (SE) 1997-09-25 — — WO disclosed
Send feedback